Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).
Politi
A
A
Department of Cardiology, S Anna Hospital, Como, Italy.
Sticca
M
M
Galli
M
M
D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015913:Chelation Therapy; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D006432:Hemochromatosis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007501:Iron; D014463:Ultrasonography; D017086:beta-Thalassemia / Q000150:complications* / Q000000981:diagnostic imaging
D007501:Iron; D003676:Deferoxamine